Skip to main content
. 2020 Dec 10;28(5):483–495. doi: 10.3727/096504020X15928179818438

Figure 2.

Figure 2

Impacts of LINC02163 silencing on the malignant properties of breast cancer cells in vitro. (A) Three siRNAs (si-LINC02163#1, si-LINC02163#2, and si-LINC02163#3) were designed to knock down endogenous LINC02163 expression in MDA-MB-231 and MCF-7 cells. RT-qPCR verified the transfection efficiency. (B) Proliferation was analyzed using the cell counting kit-8 (CCK-8) assay in MDA-MB-231 and MCF-7 cells after LINC02163 silencing. (C) Flow cytometry was conducted to determine the apoptosis rate of LINC02163-deficient MDA-MB-231 and MCF-7 cells. (D, E) The migration and invasion capacities of MDA-MB-231 and MCF-7 cells after LINC02163 silencing were evaluated using Transwell cell migration and invasion assays. *p < 0.05 and **p < 0.01.